Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dijkhuizen
Frans Dijkhuizen, Skultuna SE
| Patent application number | Description | Published |
|---|---|---|
| 20120025751 | PHOTOVOLTAIC SYSTEM - A photovoltaic system for generating an output voltage that is uninfluenced by varying irradiation, includes a photovoltaic source having an input terminal and an output terminal. The photovoltaic system includes a voltage adding arrangement having a first input terminal and an output terminal. The voltage adding arrangement is connected in series with the photovoltaic source, and includes a first route having a voltage source and a second route as a voltage source bypass. The first and second routes extend between the first input terminal and the output terminal of the voltage adding arrangement. The first and second routes being alternately activateable. | 02-02-2012 |
Lubbert Dijkhuizen, Zuidlaren NL
| Patent application number | Description | Published |
|---|---|---|
| 20090186390 | Method for the Production of Modified Steroid Degrading Microorganisms and their Use - A method is described to construct genetically modified strains of steroid degrading micro-organisms wherein the method comprises inactivation of at least one gene involved in methylhexahydroindanedione propionate degradation. Strains with (multiple) inactivated steroid degrading enzyme genes according to the invention can be used in the accumulation of steroid intermediates. Accumulation products are for example 3aα-H-4α(3′-propionic acid)-7aβ-methylhexahydro-1,5-indanedione (HIP), 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione (3-HSA), 1,4-androstadiene-3,17-dione (ADD) and 3aα-H-4α(3′-propionic acid)-5α-hydroxy-7aβ-methylhexahydro-1-indanone-δ-lactone (HIL). | 07-23-2009 |
| 20100317065 | GLUCANOTRANSFERASE - The present invention describes an isolated polypeptide which has glucanotransferase activity, selected from the group consisting of: a) a polypeptide which has an amino acid sequence which has at least 40% amino acid sequence identity with amino acids 1 to 555, 1 to 549 or 1 to 567 of SEQ ID NO: 3 or 6 or a fragment thereof; b) a polypeptide which is encoded by a polynucleotide which hybridizes under low stringency conditions with (i) the nucleic acid sequence of SEQ ID NO: 1, 2, 4 or 5 which is at least 80% or 90% identical over 60, preferably over 100 nucleotides, more preferably at least 90% identical over 200 nucleotides, or (ii) a nucleic acid sequence complementary to the nucleic acid sequence of SEQ ID NO: 1, 2, 4 or 5. | 12-16-2010 |
Lubbert Dijkhuizen, Haren NL
| Patent application number | Description | Published |
|---|---|---|
| 20110274660 | PHARMACEUTICAL COMPOSITION TO PROTECT AN ANIMAL AGAINST A DISORDER ARISING FROM AN INFECTION WITH A BACTERIUM THAT BELONGS TO THE GROUP OF NOCARDIOFORM ACTINOMYCETES - The invention pertains to a pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes having the ability to survive within macrophages of the animal, comprising live bacteria of a nocardioform actinomycetes species, the live bacteria being attenuated by inactivation of a gene that encodes a protein involved in methylhexahydroindanedione propionate degradation, and a pharmaceutically acceptable carrier for these live bacteria. | 11-10-2011 |